Alternatives to Omnix Medical

AI-driven digital twin of embryo development for cell-based therapies.

Clinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases.

AI-powered patient-centric drug simulations to accelerate and de-risk drug development.

Designs proteins with superior properties using computational analysis, evolutionary insights, and AI.

Computational platform using LLMs trained on biological and chemical data for drug discovery.

AI-powered blood test for early cancer detection and subtyping.

Biopharmaceutical company developing innovative punctal plug technology for eye disease therapies.

Compressing biology to develop the next generation of therapies.

AI-powered insights platform for life sciences and biotech workflows.

Biotechnology company developing potentially curative cell therapies for cancer patients.

Biotech company developing next-generation immunotherapy agents to unlock the immune system.

Revolutionizing prenatal testing with non-invasive fetal DNA analysis from maternal blood.

Cloud-based platform for reproducible computational research in life sciences.

Synthetic biology startup optimizing gene expression for food and biotech applications.

Clinical-stage oncology company developing small molecule therapeutics for rare tumors and aggressive cancers.

Develops and launches Padeliporfin VTP therapy for solid tumor treatment.

Clinical-stage biotech developing novel therapeutics for hematological malignancies and disorders.

Developing a semiconductor-based protein detector using nanopore sensing for advanced identification.

Developing microbiome-derived therapies to overcome resistance to immune checkpoint inhibitors in cancer treatment.

Biopharmaceutical company developing targeted neutrophil nanoparticle platform for chronic diseases.